10-years mortality risk estimation for gastric cancer patients based on clinicopathological factors
Annali Italiani di Chirurgia, cilt.93, sa.4, ss.463-469, 2022 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 93 Sayı: 4
- Basım Tarihi: 2022
- Dergi Adı: Annali Italiani di Chirurgia
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
- Sayfa Sayıları: ss.463-469
- Anahtar Kelimeler: Gastric cancer, Gastrectomy, Survival analysis, Prognosis
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
AIM: In order to create a nomogram for the gastric cancer no comprehensive study has been performed in Turkey so far and in our study, we tried to forecast the 10-year survival by using risk factors in patients without distant metastasis, who have not previously been diagnosed with another cancer but who underwent curative surgery. MATERIAL METHOD: The data of 411 patients who underwent gastrectomy for gastric cancer between January 2010 and January 2020 in Surgical Oncology Department were retrospectively examined. RESULTS: It has been shown statistically that the high RDW value point to poor survival (p <0.001). There were 173 patients with ≤3.5g/dl and 238 patients with> 3.5g/dl. It was found out statistically significant that hypoalbuminemia indicated poor survival (p <0.001). Moreover, it was determined that high CEA and Ca19-9 with lymphovascular inva-sion were to be statistically significant with prognosis (p <0.001). On the based of all this data, we have created a dekstop application for the mortality estimation. CONCLUSION: We think that this model will ensure individualization of the treatment for patients and will contribute to the patient’s compliance with the treatment by strengthening the communication between the physician. AD-ONLY G PROHIB.